Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Intern Med ; 46(21): 1809-13, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17978540

RESUMEN

We report a patient with rheumatoid arthritis (RA) who showed bicytopenia with hyperferritinemia and hepatic dysfunction ascribable to hemophagocytic syndrome (HPS) 2 weeks after commencement of bucillamine. Pathology of the bone marrow showing infiltration of macrophages confirmed the diagnosis of HPS. On the basis of renal dysfunction with an increase in fibrin degradation products, disseminated intravascular coagulation was considered to be concurrent with HPS. Oral prednisolone and cyclosporine A were started right after cessation of bucillamine, and yielded complete normalization of hepatic and renal function and hematology. As there was neither disease activity of RA nor associated infection throughout the clinical course, bucillamine was suspected of being the cause of HPS in our patient. HPS is a very rare complication in RA, but should be actively considered when abnormalities in laboratory data, especially pancytopenia and hepatic dysfunction, quickly worsen.


Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Artritis Reumatoide/complicaciones , Cisteína/análogos & derivados , Linfohistiocitosis Hemofagocítica/complicaciones , Cisteína/efectos adversos , Femenino , Humanos , Linfohistiocitosis Hemofagocítica/inducido químicamente , Persona de Mediana Edad
2.
Neuromuscul Disord ; 16(11): 763-5, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16934467

RESUMEN

We report a patient with Isaacs' syndrome associated with myasthenia gravis and pleural recurrence of thymoma, who showed severe limb pain attributed to hyperexcitability of sensory nerves. Myokymia and severe pain were successfully treated with cytoreductive surgery and intraoperative hyperthermic intrathoracic perfusion chemotherapy, but neither pharmacotherapy nor plasma exchange showed obvious clinical effects. Pleural thymoma in our patient may have caused Isaacs' syndrome, probably by unconfirmed humoral immune mechanisms. Cytoreductive treatment for recurrent thymoma should be actively considered as a potent therapeutic option in refractory patients with disabling neuromyotonia symptoms.


Asunto(s)
Síndrome de Isaacs/etiología , Síndrome de Isaacs/terapia , Miastenia Gravis/complicaciones , Recurrencia Local de Neoplasia/cirugía , Timoma/cirugía , Neoplasias del Timo/cirugía , Adulto , Electromiografía , Humanos , Síndrome de Isaacs/fisiopatología , Masculino , Músculo Esquelético/fisiopatología , Miastenia Gravis/inmunología , Miastenia Gravis/fisiopatología , Recurrencia Local de Neoplasia/complicaciones , Recurrencia Local de Neoplasia/patología , Inducción de Remisión , Timoma/complicaciones , Timoma/patología , Neoplasias del Timo/complicaciones , Neoplasias del Timo/patología , Tomografía Computarizada por Rayos X
5.
Amyloid ; 12(4): 216-25, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16399646

RESUMEN

Transthyretin (TTR) is a tetrameric protein that can dissociate into amyloidogenic monomers and cause TTR-related amyloidosis. A rare phenotype, called hereditary leptomeningeal TTR amyloidosis, in which TTR amyloid deposition occurs mainly in leptomeninges and subarachnoid vessels, has been reported in patients with several different TTR variants. In the present study, we examined TTR variants immunoprecipitated from the serum and cerebrospinal fluid (CSF) of patients with hereditary leptomeningeal TTR amyloidosis using matrix-assisted laser desorption ionization/time-of-flight mass spectrometry (IP-Mass method). The leptomeningeal-type TTR variants were not detected in the serum but were found at low levels in the CSF. The undetectable levels of the leptomeningeal-type TTR variants in serum could explain the minute amounts of systemic deposition of these variants. The relatively high level of unstable TTR variants in CSF, probably due to increased secretion from the choroid plexus, is considered to be the pathogenesis of the leptomeningeal-type of TTR amyloidosis.


Asunto(s)
Sustitución de Aminoácidos , Amiloidosis Familiar/sangre , Amiloidosis Familiar/líquido cefalorraquídeo , Mutación Puntual , Prealbúmina/análisis , Prealbúmina/líquido cefalorraquídeo , Adulto , Anciano , Amiloidosis Familiar/genética , Plexo Coroideo/metabolismo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prealbúmina/genética , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción
6.
Clin Rheumatol ; 23(3): 252-5, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15168157

RESUMEN

We report a patient with systemic lupus erythematosus (SLE) who developed fulminant pulmonary hemorrhage. This patient also showed liver dysfunction, bicytopenia and hyperferritinemia, with an increase in serum levels of interleukin (IL)-1 beta, IL-6 and tumor necrosis factor-alpha (TNF-alpha) at the onset of pulmonary symptoms, probably indicating an associated hemophagocytic syndrome. Despite an acute progressive course temporarily requiring mechanical ventilation the patient was successfully treated with continuous drip infusion of tacrolimus, plasmapheresis and intravenous high-dose immunoglobulin and corticosteroid. In this patient increased inflammatory cytokines ascribable to activation of macrophages and/or helper T cells were considered to play an important role in the pathogenesis of the pulmonary hemorrhage. Because this complication is frequently fatal in SLE, intensive therapy, including immunosuppressants and plasmapheresis, should be actively considered as early as possible after onset.


Asunto(s)
Hemorragia/inmunología , Hemorragia/terapia , Enfermedades Pulmonares/inmunología , Enfermedades Pulmonares/terapia , Lupus Eritematoso Sistémico/complicaciones , Corticoesteroides/uso terapéutico , Adulto , Femenino , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Inmunosupresores/uso terapéutico , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/terapia , Plasmaféresis , Tacrolimus/uso terapéutico , Resultado del Tratamiento
8.
J Neurol Sci ; 217(1): 7-12, 2004 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-14675602

RESUMEN

Hashimoto's encephalopathy (HE) is thought to be caused by disorders of immune mechanisms. Although immunologically mediated central nervous system vasculitis or unidentified anti-neuronal autoantibodies have been suspected of causing HE, its pathogenesis is still unclear. For the study presented here, two patients with typical clinical and laboratory/electrophysiological findings of HE were analyzed to clarify the role of anti-neuronal autoantibodies in the pathogenesis of HE. The autopsied brain of one of the patients was histopathologically examined. For Western blotting analysis and immunohistochemistry, serum and purified immunoglobulin G obtained from the other patient were used. Autopsy revealed no evidence of central nervous system vasculitis or other abnormal findings in the brain. The patient's serum contained an anti-neuronal autoantibody that immunohistochemically labeled neurons of mouse and human cerebral cortices and reacted with the 36-kDa antigenic protein present in a soluble fraction obtained from human cerebral cortex. Our results indicate that anti-neuronal autoantibodies may be associated with the pathogenesis of HE.


Asunto(s)
Autoanticuerpos/inmunología , Encefalopatías/inmunología , Neuronas/inmunología , Tiroiditis Autoinmune/inmunología , Animales , Autoanticuerpos/sangre , Western Blotting/métodos , Encefalopatías/sangre , Encefalopatías/etiología , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Inmunohistoquímica/métodos , Masculino , Ratones , Ratones Endogámicos BALB C , Persona de Mediana Edad , Tiroiditis Autoinmune/sangre , Tiroiditis Autoinmune/complicaciones
9.
Amyloid ; 11(4): 265-7, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15678762

RESUMEN

We report a characteristic finding in gadolinium-enhanced magnetic resonance images (MRIs) of the central nervous system (CNS) in a 61-year-old man with a homozygous transthyretin (TTR) Val30Met mutation. Although he presented with polyneuropathy accompanied by autonomic dysfunction and vitreous opacities in both eyes, he has shown no overt signs or symptoms of CNS involvement. Total protein level in the cerebrospinal fluid was moderately elevated. In the gadolinium-enhanced T1-weighted MRIs of the brain and spinal cord, leptomeningeal enhancement was seen along the surfaces of the brain stem and more clearly in the spinal cord, suggesting leptomeningeal TTR-related amyloid deposition. Our result indicates that gadolinium-enhanced MRI of the CNS may be a very sensitive and useful method for detecting leptomeningeal amyloid deposition, since abnormal findings can be detected even at a presymptomatic stage of CNS involvement.


Asunto(s)
Sustitución de Aminoácidos/genética , Neuropatías Amiloides/genética , Gadolinio/administración & dosificación , Imagen por Resonancia Magnética , Mutación Puntual/genética , Prealbúmina/genética , Neuropatías Amiloides/complicaciones , Neuropatías Amiloides/diagnóstico por imagen , Encéfalo/diagnóstico por imagen , Catarata/etiología , Humanos , Masculino , Metionina/genética , Persona de Mediana Edad , Radiografía , Médula Espinal/diagnóstico por imagen , Valina/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA